On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
The World Cup isn't the only global tournament underway. Thanks to Anica Badanjak and Anela Novak's new Croatian translation, the IWGDF Guidelines now reach patients in a native language on every inhabited continent on Earth — every single one.
Two diabetic foot data engines published the same day on two continents. STEADY (US) is a 5,000-patient, AI-enabled real-world registry; DARE-DiaFoot (Italy) is a deep, multi-instrumental phenotyping protocol that quietly studies remission. One is the census, the other the core sample. Together with EURODIALE, the U.S. Wound Registry, and the National Diabetes Foot Care Audit, they sketch a blueprint for finally measuring what we manage.
A new paper in BMC Health Services Research describes how we co-created a Foot Selfie app with, not for, people living with diabetes, caregivers, and clinicians in urban Lima and semi-rural Piura, Peru. Here is how the end-users redesigned remote diabetic foot surveillance to fit the rooms where it actually happens.
A new 5,698-patient real-world cohort from Valladolid (Del Río-Solá et al., Adv Wound Care 2026) reports 61.8% five-year survival overall, falling to 32.1% after major amputation — and concludes the diabetic foot ulcer should be treated as a marker of advanced systemic disease, not an isolated wound. The newest entry in a fifteen-year line of evidence putting DFU mortality squarely in the cancer conversation.
A new Queensland study from Son Nghiem, Pete Lazzarini, Lauren Ward and colleagues in Diabetic Medicine finds that investing in earlier access to diabetic foot services returns nearly $8 for every $1 spent — with lower costs, fewer hospitalisations, and better quality of life.
Ninety percent of clinicians know about the Medicare Therapeutic Shoe Benefit and nearly all recommend shoes, yet fewer than one in five eligible patients ever gets them. A new study from Ryan Crews and Carol Kurth shows the bottleneck isn't awareness. It's friction.
Forty years of the Malvern Diabetic Foot Meeting. Thirty years of mine. One last bow from Andrew Boulton in the chair. A look back at the long arc — from a Benedictine priory in 1085 to Joslin in 1928 to DFCon in 2000 to ALPS in 2020 — and a look forward to DFCon 26, DFUpdate, traveling fellowships, and the next generation already climbing the hill.
Yu and colleagues from Ken Muneoka's group show that sequential FGF2 then BMP2 treatment flips an adult mouse digit amputation from fibrosis to regeneration — rebuilding the distal phalanx with a growth plate, plus a parallel response that regenerates a synovial joint complex with tendon, ligament, and a sesamoid-like bone. The regeneration-competent cells are already in our wound beds. We just have to learn what to say to them.
Johann Georg Mönckeberg was a Hamburg patrician, born in 1877. His father — same name — was a senator of the free city, with the Mönckebergstrasse running from the Rathaus to the Hauptbahnhof named after him. The son grew up in a household where the name was already on the streets. He studied medicine at... Continue Reading →
Google Scholar ticked over to 95,006 citations overnight. The number is real — the story behind it isn't mine. An h-index of 134 and an i10-index of 568 reflect 568 conversations between collaborators, residents, fellows, patients, and friends. A note on what citations actually are, why limb preservation is and always will be a team sport, and gratitude to everyone whose hand has been on the work.
